USPTO serial 79461338
WE'RE HUMAN
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- BROOKSHIRE, DAVID AARON
- Law office
- TMO LAW OFFICE 137
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with WE'RE HUMAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media [other than for medical or veterinary use]; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells [other than for medical use]; proteins for use in recombinant DNA technology [other than for medical use]. | ACTIVE | — |
| 005 | Cell therapeutics; genetically or otherwise modified cells; cells which are propagated, cultivated and expanded in bioreactors; cells for the purpose of tissue regeneration; living cells for medical use; cells for medical use; biological preparations for medical use; diagnostic preparations for medical and/or veterinary purposes; cell preparations for drug screening; cell preparations for genetic testing, screening; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use; tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells; cell separation reagents. | ACTIVE | — |
| 040 | Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media [other than for medical or veterinary use], chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells [other than for medical use], proteins for use in recombinant DNA technology [other than for medical use], cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and/or veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing, screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents. | ACTIVE | — |
| 042 | Biotechnology research; biotechnology testing; stem cell research; synthetic biology services; stem cell biology services; scientific services relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testing, screening; research and development in relation to drug screening; cell separation technology services; cell separation research services; consultancy relating to biotechnology; consultancy relating to drug screening; consultancy relating to genetic screening; consultancy relating to cell therapy; laboratory research. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 1, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 31, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 22, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |